Pharma Lab Sibutramine 50 tabs (20 mg/tab)

Sibutramine

Sibutramine tablets support weight loss in individuals struggling with obesity when paired with a low-calorie diet. Users typically experience significant weight reduction within the initial six-month regimen of Sibutramine alongside diet and exercise.

Developed by Abbott Laboratories, Sibutramine is marketed under two distinct brand names: Meridia® in the USA, and Reductil® in Europe. Initially, pharmaceuticals are marketed under patents, limiting sales to the original developers. However, generic drugs, like Sibutramine, become available once the patent expires, offering a more affordable option without compromising effectiveness.

Generics must mirror the original in active ingredients. They are designed to match the same dosage, strength, route of administration, safety, efficacy, and intended use. Generally, generics hit the market post-patent expiration, promoting competition that significantly reduces prices for both brand and generic versions.

Dosage

10-20 mg/day – variation